Search
|
Browse by Day
|
Author Index
Author Index: A
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Aas, A.
COST-EFFECTIVENESS OF INTENSIVE LIFESTYLE INTERVENTION IN PATIENTS WITH POORLY CONTROLLED TYPE 2 DIABETES
Aasland, O. G.
EXPLAINING RISK REDUCTIONS TO PATIENTS: DO PHYSICIANS USE NUMBERS?
SO MUCH FOR SHARED DECISION MAKING? GENERAL PRACTITIONERS' BELIEFS VERSUS PATIENT PREFERENCES FOR SURVIVAL GAINS
Abi Nahed, J.
SIMULATION TRAINING AND DECISION SUPPORT FOR MEDICAL EDUCATION
Abisheganaden, J.
EFFECTIVENESS OF ACUTE GERIATRIC UNITS: EXPLORING HETEROGENEITY OF TREATMENT EFFECT AMONG SENIORS HOSPITALIZED FOR PNEUMONIA
Aertgeerts, B.
HOW MANY MORE PATIENTS WILL WE TREAT BY DECREASING THE THRESHOLD?
Agatisa, P.
NEW TECHNOLOGY, NEW CHALLENGES: BARRIERS TO INFORMED DECISION-MAKING FOR FIRST TRIMESTER ANEUPLOIDY SCREENING
Aikin, K. J.
INFLUENCES ON PHYSICIANS' ASSESSMENTS AND DECISIONS REGARDING PRESCRIPTION DRUG EFFECTIVENESS
Aissa, F.
COST-EFFECTIVENESS IN CANADA OF RITUXIMAB FOR PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Aivas, I.
REDUCING PATIENT WAIT TIMES FOR RADIATION THERAPY AND IMPROVING THE RADIATION TREATMENT PLANNING EFFICIENCY WITH THE AID OF A DISCRETE-EVENT SIMULATION MODEL
Alagoz, O.
OPTIMAL COLONOSCOPY SCREENING POLICIES FOR COLORECTAL CANCER PREVENTION AND SURVEILANCE
MUTUAL INFORMATION ANALYSIS USED TO DETERMINE MOST INFORMATIVE FEATURES IN BREAST CANCER DIAGNOSIS
DESIGNING RISK-TAILORED BREAST CANCER SCREENING POLICIES CONSIDERING IMPERFECT ADHERENCE
CONCURRENT ORAL SESSION D: SIMULATION AND HEALTH TECHNOLOGY ASSESSMENT APPLICATIONS
MEDICAL DECISION MAKING WITH BAYESIAN NETWORKS
THE EFFECT OF BUDGETARY RESTRICTIONS ON THE OPTIMAL DECISION THRESHOLDS FOR BREAST CANCER DIAGNOSIS
Alam, A.
PREDICTION OF CARDIAC OUTCOMES BY PHYSICIANS VS PRACTICE GUIDELINES
Albin, L.
CARE COORDINATION: WHAT WORKS? MAKING SENSE OF A VAST LITERATURE VIA A SYSTEMATIC REVIEW OF REVIEWS
Aldrich, D. G.
COMPARISON OF VARIANTS OF A COMPUTERIZED CHEST PAIN DIAGNOSIS TUTOR
Alford, S. M. H.
INFORMATION OVERLOAD IN BREAST CANCER DECISION MAKING: WHEN TWO CHOICES ARE TOO MANY
Alibhai, S. M.
THE IMPACT OF VALUES CLARIFICATION IN A DECISION AID: EVIDENCE FROM A RANDOMIZED CONTROLLED TRIAL EMERGES SLOWLY OVER TIME
Alistar, S. S.
DECISION MAKING FOR HIV PREVENTION AND TREATMENT SCALE UP: BRIDGING THE GAP BETWEEN THEORY AND PRACTICE
Allen, C.
COST-UTILITY OF LAPAROSCOPIC NISSEN FUNDOPLICATION VERSUS PROTON PUMP INHIBITORS FOR GASTRO-ESOPHAGEAL REFLUX DISEASE: A 3-YEAR PROSPECTIVE RANDOMIZED CONTROLLED TRIAL AND ECONOMIC EVALUATION
Allen, R. B.
MULTISTAGE VIRTUALLY EXPERIENCED PATIENT DECISION MAKING
Alonso, E. M.
WITHDRAWAL OF IMMUNOSUPPRESSION FOLLOWING PEDIATRIC LIVER TRANSPLANTATION: A MARKOV ANALYSIS
Alonso, L.
IMPROVING DIAGNOSIS: STARTING A LOCAL STRATEGY
Alweis, R.
A CASE OF IATROGENIC HYPERTHYROIDISM
HIV – ESTABLISHMENT AND PERPETUATION OF AN INCORRECT DIAGNOSIS
MULTIPLE EXPOSURES TO HEPATITIS B IN A HEMODIALYSIS UNIT
Ament, A.
IMPLEMENTING GUIDELINES INTO CLINICAL PRACTICE: WHAT IS THE VALUE?
Ananworanich, J.
ECONOMIC EVALUATION OF MONITORING VIROLOGIC RESPONSES TO ANTIRETROVIRAL THERAPY IN HIV-INFECTED CHILDREN IN RESOURCE-LIMITED SETTINGS
Anglaret, X.
PATIENT- AND POPULATION-LEVEL HEALTH CONSEQUENCES OF DISCONTINUING ANTIRETROVIRAL THERAPY (ART) IN RESOURCE-LIMITED SETTINGS
Angott, A. M.
IMPRECISE DEFINITIONS OF “PRECISE”: PREFERENCES FOR PRECISION DEPEND ON CONTEXT
COLOSTOMY IS BETTER THAN DEATH, BUT A 4% CHANCE OF DEATH MIGHT BE BETTER THAN A 4% CHANCE OF COLOSTOMY: WHY PEOPLE MAKE CHOICES SEEMINGLY AT ODDS WITH THEIR STATED PREFERENCES
Anis, A. H.
COST-EFFECTIVENESS OF NOVEL ANTIRETROVIRALS FOR HUMAN IMMUNODEFICIENCY VIRUS INFECTION
THE COST-EFFECTIVENESS OF HEROIN ASSISTED TREATMENT FOR CHRONIC, TREATMENT-REFRACTORY OPIOID ADDICTS
USING A DISCRETE CHOICE EXPERIMENT TO ESTIMATE HEALTH STATE UTILITY VALUES
Antiel, R. A.
THE MORAL PSYCHOLOGY OF RATIONING AMONG PHYSICIANS: THE ROLE OF HARM AND FAIRNESS INTUITIONS IN PHYSICIAN OBJECTIONS TO COST-EFFECTIVENESS AND COST-CONTAINMENT
Antoni, M.
ONCOLOGISTS' ATTITUDES AND BELIEFS ABOUT PATIENT PARTICIPATION IN CANCER CLINICAL TRIALS
Anvari, M.
COST-UTILITY OF LAPAROSCOPIC NISSEN FUNDOPLICATION VERSUS PROTON PUMP INHIBITORS FOR GASTRO-ESOPHAGEAL REFLUX DISEASE: A 3-YEAR PROSPECTIVE RANDOMIZED CONTROLLED TRIAL AND ECONOMIC EVALUATION
Aoki, N.
DEVELOPMENT OF DECISION SUPPORT SYSTEM FOR SUBJECTS TESTED POSITIVE FOR CANCER
Appel, E.
A COST COMPARISON OF OPTIMAL VERSUS SUB-OPTIMAL PRE-DIALYSIS CARE IN CANADA BASED ON THE STARRT TRIAL
Applebee, D.
IS THERE A NEED FOR A PATIENT DECISION AID FOR PRENATAL SCREENING?: PRENATAL PATIENTS' REPORTS ABOUT THEIR DECISION PROCESS
Arbuckle, E. E.
COMPARISON OF VARIANTS OF A COMPUTERIZED CHEST PAIN DIAGNOSIS TUTOR
Arden, N.
PREFERENCES FOR THE BENEFITS AND RISKS OF NSAIDS AMONG OSTEOARTHRITIS PATIENTS IN THE UK
Arrick, B. A.
SHARED DECISION MAKING FOR WOMEN WITH BREAST CANCER: KNOWLEDGE, VALUES, AND DECISIONAL CONFLICT OVER TIME
Auerbach, H. R.
WILLINGNESS TO PAY FOR PREDICTIVE DIAGNOSTIC INFORMATION WITH NO IMMEDIATE TREATMENT IMPLICATIONS: A SURVEY OF U.S. RESIDENTS
Augestad, L. A.
TESTING THE ACCURACY OF COMPOSITE HEALTH STATE UTILITY ESTIMATORS – AN ANALYSIS OF MEDICAL CONDITION PAIRS FROM MEPS 2001 AND 2003
LEARNING EFFECTS IN EQ-5D TIME TRADE-OFF VALUATIONS
Augusto, Jr., V.
MODELING PERFORMANCE OF IMAGING : A NEW PROPOSITION FOR PERFORMANCE APPRAISAL
Aultman, R.
COST-EFFECTIVENESS IN CANADA OF RITUXIMAB FOR PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Austin, P. C.
PROPENSITY SCORE METHODS FOR ESTIMATING CAUSAL TREATMENT EFFECTS USING OBSERVATIONAL DATA
Ayer, T.
DESIGNING RISK-TAILORED BREAST CANCER SCREENING POLICIES CONSIDERING IMPERFECT ADHERENCE
Ayvaci, M. U.
MUTUAL INFORMATION ANALYSIS USED TO DETERMINE MOST INFORMATIVE FEATURES IN BREAST CANCER DIAGNOSIS
MEDICAL DECISION MAKING WITH BAYESIAN NETWORKS
THE EFFECT OF BUDGETARY RESTRICTIONS ON THE OPTIMAL DECISION THRESHOLDS FOR BREAST CANCER DIAGNOSIS
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z